Regulation of TNF-alpha by 1 alpha,25-dihydroxyvitamin D-3 in human macrophages from CAPD patients

Citation
Ml. Cohen et al., Regulation of TNF-alpha by 1 alpha,25-dihydroxyvitamin D-3 in human macrophages from CAPD patients, KIDNEY INT, 59(1), 2001, pp. 69-75
Citations number
36
Categorie Soggetti
Urology & Nephrology","da verificare
Journal title
KIDNEY INTERNATIONAL
ISSN journal
00852538 → ACNP
Volume
59
Issue
1
Year of publication
2001
Pages
69 - 75
Database
ISI
SICI code
0085-2538(200101)59:1<69:ROTB1A>2.0.ZU;2-O
Abstract
Background We have previously reported that 1 alpha ,25-dihydroxyvitamin D- 3 [1 alpha ,25(OH)(2)D-3] accumulates in the dialysis fluid of uremic patie nts treated by continuous ambulatory peritoneal dialysis (CAPD). It has bee n reported that this metabolite regulates the production of cytokines by mo nocytes/macrophages. Since tumor necrosis factor-alpha (TNF-alpha) initiate s an inflammatory cascade during peritonitis, the aim of the present study was to investigate the effect of 1 alpha ,25(OH)(2)D-3 on the production of TNF-alpha by human peritoneal macrophages (HPMs). Methods. HPMs were obtained from patients on CAPD. Cells were incubated wit h various concentrations of 1 alpha ,25(OH)(2)D-3, 1 alpha ,24(S) dihydroxy vitamin D-2 [1 alpha ,24(S)(OH)(2)D-2] Or 25-hydroxyvitamin D-3 (25-OH-D-3) for 16 hours. This was followed by lipopolysaccharide (LPS; 1 mug/mL) incu bation for 2.5 to 6 hours. TNF-alpha protein production was determined by e nzyme-linked immunosorbent assay. TNF-alpha mRNA was assayed by the reverse transcriptase-polymerase chain reaction procedure, using internal syntheti c mRNA standards for quantitative results. Results. Incubation of HPMs with 1 alpha ,25(OH)(2)D-3 prior to stimulation with LPS dose dependently inhibited the expression of TNF-alpha on both mR NA and protein levels. Similar results were obtained with the less calcemic vitamin D-2 analogue 1 alpha ,24(S)(OH)(2)D-2. Incubation of HPMs with 25- OH-D-3 also revealed a down-regulation of TNF-alpha. expression. Since this down-regulatory effect was blocked by ketoconazole, it is likely that this effect was caused by the conversion of 25-OH-D-3 into 1 alpha ,25(OH)(2)D- 3 by HPMs. Conclusions. 1 alpha ,25(OH)(2)D-3 has a potent inhibitory effect on the pr oduction of TNF-alpha by LPS-activated HPMs. We hypothesize that 1 alpha ,2 5(OH)(2)D-3 may constitute a regulatory mechanism that, by controlling the intensity of the inflammatory response of the peritoneum, will moderate tis sue damage during peritonitis.